GlassScriptPhysician profile
Timothy B Hadden
NPI 1639154461
$5,708.00
in general payments reported to CMS, 2019-2025
22 companies · $407 in 2025
The $407 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,981 · 2020: $2,164 · 2021: $53.60 · 2022: $470 · 2023: $487 · 2024: $146 · 2025: $407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,040.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,039.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,739.88 | 2019-2020 | |
| Shockwave Medical, INC | $693.38 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $263.55 | 2019-2025 | |
| Abbott Laboratories | $256.97 | 2021-2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Janssen Pharmaceuticals, INC | $188.10 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $175.11 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $171.23 | 2019-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $170.23 | 2022 | |
| Amgen INC. | $158.18 | 2019-2020 | |
| Recor Medical INC | $146.35 | 2024 | Paradise Renal Denervation System |
| Astellas Pharma US INC | $139.99 | 2019 | |
| Sanofi-Aventis U.S. LLC | $115.59 | 2019 | |
| Pfizer INC. | $77.35 | 2019-2023 | |
| Regeneron Healthcare Solutions, INC. | $74.04 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $70.71 | 2019-2025 | Lifevest |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $70.41 | 2019-2020 | |
| Medtronic Vascular, INC. | $48.97 | 2019 | |
| Philips North America LLC | $38.48 | 2020-2023 | |
| Bardy Diagnostics, INC. | $35.00 | 2019-2020 | |
| Penumbra, INC. | $34.72 | 2022 | |
| Cardiovascular Systems INC. | $22.67 | 2023 | Diamondback Peripheral |
| Braemar Manufacturing, LLC | $17.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Hadden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.